Clinical outcomes of HIV-1 infected patients switched from complex multi-tablet regimens to tenofovir alafenamide based single-tablet regimens plus a boosted protease inhibitor in a real-world setting

• Asıl Yazarlar: Charlotte-Paige Rolle (Yazar), Vu Nguyen (Yazar), Federico Hinestrosa (Yazar), Edwin DeJesus (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Elsevier, 2020-11-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Background: Multi-tablet regimens (MTRs) are associated with increased adverse events and non-adherence. Single tablet regimens (STRs) plus boosted protease inhibitors (PIs) are a simplification option for MTR-treated patients; however, data is needed to validate this therapeutic strategy. Methods:...